The Magazine for Sleep Professionals
Thursday, April 30, 2026
The email below was sent to Philips’ CPAP users on October 15, 2022 We are pleased to share an important update regarding your Philips device replacement. Philips received authorization from the US Food and Drug Administration (FDA) for the repair and replacement program for devices impacted by the June 14, […]
“The ATS reiterates our long-held position – e-cigarettes are not “safe” and the claims that e-cigarettes are a harm reduction tool remain unproven. All e-cigarettes have significant health risks including nicotine addiction and respiratory disease,” said ATS President Lynn Schnapp, MD, ATSF. The ATS notes that the FDA has finally issued decisions […]
To meet the need for safe, effective and reliable non-invasive ventilation (NIV) throughout the care continuum, Dräger has launched the new Savina 300 NIV, the latest ventilator in its Savina 300 family of ventilators. Built to Dräger’s exceptionally high standards and backed by its 100+ years of experience in mechanical ventilation, […]
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced the launch of Inhaler Tales – a national campaign aimed at raising awareness about the role inhaler misuse may play in inadequate disease control.1 Central to the campaign is an animated inhaler voiced by actress, producer, and entrepreneur Sarah […]
By Nathan Costiuc, MSN, APRN, FNP-BC There’s no denying that reliable respiratory equipment has become critical amid the COVID-19 pandemic. Yet new patient concerns have recently resulted from the June 14 Philips Respironics recall of several models of ventilators, BiPAP and CPAP machines due to a manufacturing defect. After navigating […]
The Food and Drug Administration issued decisions on new tobacco product applications, addressing the over 6 million unique products and flavor variations submitted for agency review. Missing from the FDA’s announcement was a decision on a company that has the largest e-cigarette market share – Juul. “How the FDA could […]
ResMed today launched AirSense 11, available first in the U.S., the company’s next-generation PAP (positive airway pressure) device designed to help hundreds of millions of people worldwide with sleep apnea1 start and stay on therapy to treat and manage obstructive sleep apnea. AirSense 11 includes new features like Personal Therapy […]
Philip Morris International Inc. announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a late-stage inhalable acetylsalicylic acid (ASA) treatment for acute myocardial infarction. If approved, the treatment can address the significant unmet medical need of the over 83 million people, in the U.S. alone, at intermediate […]
CPAP Supply Statement “With the announcement of the suspension of shipping of PAP devices by Philips Respironics, 3B Medical has put together guidance for companies ordering CPAP. As always, 3B Medical will always give first priority to customers that have supported the company over the long term. Starting last week and concluding […]
Women who were highly exposed to ultrafine particles in air pollution during their pregnancy were more likely to have children who developed asthma, according to a study published in the American Journal of Respiratory and Critical Care Medicine. This is the first time asthma has been linked with prenatal exposure […]
